Φορτώνει......
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells
Phosphatase and tensin homolog (PTEN) gene is considered a tumor suppressor gene. However, PTEN mutations rarely occur in hepatocellular carcinoma (HCC), whereas heterozygosity of PTEN, resulting in reduced PTEN expression, has been observed in 32–44% of HCC patients. In the present study, we invest...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Cycle |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056616/ https://ncbi.nlm.nih.gov/pubmed/26794644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1138183 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|